Browse by UCL Departments and Centres
![]() | Up a level |
Group by: Author | Type
Number of items: 20.
A
| ACRES, RB and LAMB, JR and BEVERLEY, PCL and FELDMANN, M (1984) EFFECTS OF EPIDERMAL GROWTH-FACTOR (EGF) AND PLATELET DERIVED GROWTH-FACTOR (PDGF) ON ANTIGEN DRIVEN LYMPHOCYTE-T PROLIFERATION INVITRO. IMMUNOBIOLOGY , 167 (1-3) 254 - 254. |
| ALISON, DL and MOONEY, C and ROBINSON, B and SMITH, IE and WILTSHAW, E and MCELWAIN, TJ and CALVERT, AH (1984) PHASE-I CLINICAL-TRIAL OF CB3717 ((N-(4-(N-((2-AMINO-4-HYDROXY-6-QUINAZOLINYL)METHYL)PROP-2-YNYLAMINO)BENZOYL)-L-GLUTAMIC ACID). INVEST NEW DRUG , 2 (1) 107 - 107. |
| ANDO, I and CRAWFORD, DH and HARIRI, G and WALLACE, D and BEVERLEY, PCL (1984) TUMOR PROMOTER PHORBOL ESTERS INDUCE IL-2 RECEPTOR IN T-CELLS AND B-CELLS AND ANTIGEN SPECIFIC UNRESPONSIVENESS IN LYMPHOCYTES-T. IMMUNOBIOLOGY , 167 (1-3) 81 - 81. |
B
| Barratt, GM and Ryman, BE and Chester, KA and Begent, RHJ (1984) Liposomes as aids to tumor-detection. Biochemical Society Transactions , 12 (2) 348 - 349. |
| Begent, RHJ and Green, AJ and Chester, KA and Keep, PA and Searle, F and Bagshawe, KD (1984) The use of 2nd antibody to improve selective localization of tumours- clinical studies. In: British Journal of Cancer. (pp. 556 - 556). |
| BEVERLEY, PCL and WALLACE, D and ZANDERS, ED and OFLYNN, K and LINCH, D (1984) HUMAN LYMPHOCYTE-T ACTIVATION INVESTIGATED USING MITOGENIC MONOCLONAL-ANTIBODIES. IMMUNOBIOLOGY , 167 (1-3) 241 - 241. |
C
| CALVERT, AH and ALISON, DL and WILTSHAW, E and BAKER, JW and ROBINSON, B and MOONEY, C and MCELWAIN, TJ and HARRAP, KR (1984) EARLY CLINICAL-STUDIES WITH CB3717 ((N-(4-(N-(2-AMINO-4-HYDROXY-6-QUINAZOLINYL)METHYL)PROP-2-YNYLAMINO)BENZOYL)-L-GLUTAMIC ACID. P AM ASSOC CANC RES , 25 (MAR) 165 - 165. |
| CALVERT, AH and WILTSHAW, E and BAKER, JW and SMITH, IE (1984) PHASE-II AND PHASE-III STUDIES WITH CARBOPLATIN (JM8, CBDCA). INVEST NEW DRUG , 2 (1) 105 - 105. |
| Chester, KA and Begent, RHJ (1984) Circulating immune-complexes (CIC),carcinoembryonic antigen(CEA)and CIC containing CEA as markers for colorectal-cancer. Clinical and Experimental Immunology , 58 (3) 685 - 693. |
| Chester, KA and Begent, RHJ and Pedley, B and Keep, PA and Boden, JA and Searle, F and Bagshawe, KD (1984) The use of 2nd antibody to improve selective localization of tumours-animal-model studies. British Journal of Cancer , 50 (4) 556 - 556. |
| Chester, KA and Begent, RHJ and Pedley, RB and Keep, PA and Boden, JA and Searle, FABKD (1984) The use of second antibody to improve selective localisation of tumours: animal model studies. In: (Proceedings) Proceedings BACR. (pp. 365 - ?). |
H
| HARLAND, SJ and CALVERT, AH and JONES, M and SIDDIK, Z and HARRAP, KR (1984) MECHANISM OF RESISTANCE TO METHOTREXATE (MTX) IN HUMAN-TUMOR XENOGRAFTS. BRIT J CANCER , 50 (2) 263 - 263. |
| HARLAND, SJ and NEWELL, DR and SIDDIK, ZH and CHADWICK, R and CALVERT, AH and HARRAP, KR (1984) PHARMACOKINETICS OF CIS-DIAMMINE-1,1-CYCLOBUTANE DICARBOXYLATE PLATINUM(II) IN PATIENTS WITH NORMAL AND IMPAIRED RENAL-FUNCTION. CANCER RES , 44 (4) 1693 - 1697. |
J
| JACKMAN, AL and CALVERT, AH and HART, LI and HARRAP, KR (1984) INHIBITION OF THYMIDYLATE SYNTHETASE BY THE NEW QUINAZOLINE ANTIFOLATE, CB-3717 - ENZYME-PURIFICATION AND KINETICS. ADV EXP MED BIOL , 165 375 - 378. |
| JACKMAN, AL and TAYLOR, GA and CALVERT, AH and HARRAP, KR (1984) MODULATION OF ANTI-METABOLITE EFFECTS - EFFECTS OF THYMIDINE ON THE EFFICACY OF THE QUINAZOLINE-BASED THYMIDYLATE SYNTHETASE INHIBITOR, CB3717. BIOCHEM PHARMACOL , 33 (20) 3269 - 3275. |
L
| LEWIS, JCM and BOXER, GM and SEARLE, F and BAGSHAWE, KD (1984) THE COMPARATIVE DISTRIBUTION OF MONOCLONAL-ANTIBODIES TO CEA IN COLORECTAL XENOGRAFTS. TUMOUR BIOL , 5 (5) 255 - 261. |
N
| NEWELL, DR and ALISON, DL and JACKMAN, AL and CALVERT, AH and HARRAP, KR (1984) STUDIES ON THE MECHANISM OF CB3717 INDUCED HEPATOTOXICITY. BRIT J CANCER , 50 (2) 264 - 264. |
| NEWELL, DR and HARLAND, SJ and SIDDIK, ZH and CALVERT, AH and HARRAP, KR (1984) THE CLINICAL PHARMACOKINETICS OF CARBOPLATIN (JM8, CBDCA). INVEST NEW DRUG , 2 (1) 104 - 104. |
S
| SMITH, IE and HARLAND, SJ and ROBINSON, B and CALVERT, AH (1984) CIS-DIAMMINE-I, I-CYCLOBUTANE DICARBOXYLATE PLATINUM-II (CBDCA, JM8) - AN ACTIVE NEW CISPLATIN ANALOG IN THE TREATMENT OF SMALL CELL LUNG-CANCER (SCLC). INVEST NEW DRUG , 2 (1) 105 - 105. |
T
| TAYLOR, GA and JACKMAN, AL and CALVERT, AH and HARRAP, KR (1984) PLASMA NUCLEOSIDE AND BASE LEVELS FOLLOWING TREATMENT WITH THE NEW THYMIDYLATE SYNTHETASE INHIBITOR-CB-3717. ADV EXP MED BIOL , 165 379 - 382. |


